ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19
Clinical trial NCT04393038 · TERMINATED
Trial details
- NCT number
- NCT04393038
- Sponsor
- Abivax S.A.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2021-03-05
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.